antibiotics, antimalarials and cancer medicines. Moreover, for the twelfth consecutive year, Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI). The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2020 employed more than 100,000 people worldwide. In 2020, Roche invested CHF 12.2 billion in R&D and posted sales of CHF 58.3 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit https://www.globenewswire.com/Tracker?data=IHCnyDSRv6Guv36ciBLdXsymRPjnx4yf9nT7f6CnOeV3yH9jB-AXPj7HLtI2vx7qWDBxclEsc_NdSICKiimkXQ== www.roche.com. All trademarks used or mentioned in this release are protected by law. Roche Group Media Relations Phone: +41 61 688 8888 / e-mail: https://www.globenewswire.com/Tracker?data=tOilpWsI5JE2kpWDUrnPNqA1tQ5txm90VrWMfgWoWw49gEkajU1G9XZY6kzSlroCBO8TwGc2tBS0Mlkwz10flGDcy8uSMJY8kQAQn6XVFRG5s7oXjbRRroSYapcUdY0Q media.relations@roche.com Dr. Nicolas Dunant Patrick Barth Phone: +41 61 687 05 17 Phone: +41 61 688 44 86 Dr. Daniel Grotzky Karsten Kleine Phone: +41 61 688 31 10 Phone: +41 61 682 28 31 Nina Mählitz Nathalie Meetz Phone: +41 79 327 54 74 Phone: +41 61 687 43 05 Dr. Barbara von Schnurbein Phone: +41 61 687 89 67 Roche Investor Relations Dr. Karl Mahler Jon Kaspar Bayard Phone: +41 61 68-78503 Phone: +41 61 68-83894 e-mail: mailto:karl.mahler@roche.com e-mail: mailto:jon_kaspar.bayard@roche.com karl.mahler@roche.com jon_kaspar.bayard@roche.com -------------------------------------------- ------------------------------------------- Dr. Sabine Borngräber Dr. Bruno Eschli Phone: +41 61 68-88027 Phone: +41 61 68-75284 e-mail: mailto:sabine.borngraeber@roche.com e-mail: mailto:bruno.eschli@roche.com sabine.borngraeber@roche.com bruno.eschli@roche.com -------------------------------------------- ------------------------------------------- Dr. Birgit Masjost Dr. Gerard Tobin Phone: +41 61 68-84814 Phone: +41 61 68-72942 e-mail: mailto:birgit.masjost@roche.com e-mail: mailto:gerard.tobin@roche.com birgit.masjost@roche.com gerard.tobin@roche.com -------------------------------------------- ------------------------------------------- Investor Relations North America Loren Kalm Dr. Lisa Tuomi Phone: +1 650 225 3217 Phone: +1 650 467 8737 e-mail: mailto:kalm.loren@gene.com e-mail: mailto:tuomi.lisa@gene.com kalm.loren@gene.com tuomi.lisa@gene.com -------------------------------------------- ------------------------------------------- Attachment -- 16042021_MR_AAN MS Data https://ml-eu.globenewswire.com/Resource/Download/79d49b3c-3cad-4191-b75f-ea6901de1eca
(END) Dow Jones Newswires
April 16, 2021 01:00 ET (05:00 GMT)